Abstract Details
|
Zoya Zaeem, MD
PRESENTER |
Dr. Zaeem has nothing to disclose. |
| Collin C. Luk, MD (University of Calgary) | Dr. Luk has nothing to disclose. |
| Dustin M. Anderson, MD | No disclosure on file |
| Gregg G. Blevins, MD, FRCP(C) (University of Alberta) | Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-roche. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. The institution of Dr. Blevins has received research support from Novartis. Dr. Blevins has received research support from Hoffman La-Roche. The institution of Dr. Blevins has received research support from EMD Serono. Dr. Blevins has received research support from Biogen Idec. The institution of Dr. Blevins has received research support from MS society of Canada. The institution of Dr. Blevins has received research support from Canadian Institutes of Health Research . |
| Zaeem A. Siddiqi, MD, PhD (University of Alberta Hospital) | Dr. Siddiqi has nothing to disclose. |